Company record
AmideBio, LLC manufactures peptide drug candidates focused on metabolic disease therapeutics. Its portfolio includes murine insulins, oxyntomodulin, amyloid peptides, Bowman‑Birk protease inhibitors, a range of toxins, and knottin scaffolds. The company supplies these specialized peptides to both biopharmaceutical firms and academic or contract research organizations.
This directory record does not yet have a linked material-flow brief.